Role of S-nitrosylation in apoptosis resistance and carcinogenesis

Nitric Oxide - Biology and Chemistry

Volumn 19, Issue 2, 2008, Pages 146-151

  Iyer, Anand Krishnan V ^a   Azad, Neelam ^a   Wang, Liying ^b   Rojanasakul, Yon ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Apoptosis; Bcl 2; FLIP; Nitric oxide; S Nitrosylation; Ubiquitination

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; FLICE INHIBITORY PROTEIN; NITRIC OXIDE; PROTEIN BCL 2; THIOL GROUP;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; NITROSYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; UBIQUITINATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NITRIC OXIDE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 47049087270     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.04.019     Document Type: Article

References (65)

1. Mocellin S., Bronte V., and Nitti D. Nitric oxide a double edged sword in cancer biology: searching for therapeutic opportunities. Medicinal Research Reviews 27 (2007) 317-352
2. Chang W.C., Chapkin R.S., and Lupton J.R. Predictive value of proliferation differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 18 (1997) 721-730
3. Morin P.J., Vogelstein B., and Kinzler K.W. Apoptosis and APC in colorectal tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 7950-7954
4. Xu W., Liu L.Z., Loizidou M., Ahmed M., and Charles I.G. The role of nitric oxide in cancer. Cell Research 12 (2002) 311-320
5. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., and Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19 (1998) 711-721
6. Knowles R.G., and Moncada S. Nitric oxide synthases in mammals. The Biochemical Journal 298 Pt 2 (1994) 249-258
7. Fukumura D., Kashiwagi S., and Jain R.K. The role of nitric oxide in tumour progression. Nature Reviews Cancer 6 (2006) 521-534
8. Thomsen L.L., and Miles D.W. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Reviews 17 (1998) 107-118
9. Lala P.K., and Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Reviews 17 (1998) 91-106
10. Lancaster Jr. J.R., and Xie K. Tumors face NO problems?. Cancer Research 66 (2006) 6459-6462
11. Lala P.K., and Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncology 2 (2001) 149-156
12. Ridnour L.A., Thomas D.D., Donzelli S., Espey M.G., Roberts D.D., Wink D.A., and Isenberg J.S. The biphasic nature of nitric oxide responses in tumor biology. Antioxidants & Redox Signaling 8 (2006) 1329-1337
13. Sawa T., and Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 14 (2006) 91-100
14. Hirst D., and Robson T. Targeting nitric oxide for cancer therapy. The Journal of Pharmacy & Pharmacology 59 (2007) 3-13
15. Stamler J.S., Simon D.I., Osborne J.A., Mullins M.E., Jaraki O., Michel T., Singel D.J., and Loscalzo J. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 444-448
16. Fukuo K., Hata S., Suhara T., Nakahashi T., Shinto Y., Tsujimoto Y., Morimoto S., and Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27 (1996) 823-826
17. Hara M.R., and Snyder S.H. Nitric oxide-GAPDH-Siah: a novel cell death cascade. Cellular & Molecular Neurobiology 26 (2006) 527-538
18. Kuzushima M., Mogi M., and Togari A. Cytokine-induced nitric-oxide-dependent apoptosis in mouse osteoblastic cells: involvement of p38MAP kinase. Archives of Oral Biology 51 (2006) 1048-1053
19. Li C.Q., Robles A.I., Hanigan C.L., Hofseth L.J., Trudel L.J., Harris C.C., and Wogan G.N. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Research 64 (2004) 3022-3029
20. Azad N., Vallyathan V., Wang L., Tantishaiyakul V., Stehlik C., Leonard S.S., and Rojanasakul Y. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. The Journal of Biological Chemistry 281 (2006) 34124-34134
21. Chanvorachote P., Nimmannit U., Stehlik C., Wang L., Jiang B.H., Ongpipatanakul B., and Rojanasakul Y. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Research 66 (2006) 6353-6360
22. Chanvorachote P., Nimmannit U., Wang L., Stehlik C., Lu B., Azad N., and Rojanasakul Y. Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. The Journal of Biological Chemistry 280 (2005) 42044-42050
23. Delikouras A., Hayes M., Malde P., Lechler R.I., and Dorling A. Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 71 (2001) 599-605
24. Kim Y.M., Talanian R.V., and Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. The Journal of Biological Chemistry 272 (1997) 31138-31148
25. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A.J., and Stamler J.S. Fas-induced caspase denitrosylation. Science 284 (1999) 651-654
26. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78 (1994) 931-936
27. Stamler J.S., Toone E.J., Lipton S.A., and Sucher N.J. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18 (1997) 691-696
28. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., and Stamler J.S. Protein S-nitrosylation: purview and parameters. Nature Reviews Molecular Cellular Biology 6 (2005) 150-166
29. Stamler J.S., Toone E.J., Lamas S., and Fang F.C. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106 (2001) 675-683
30. DelaTorre A., Schroeder R.A., and Kuo P.C. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochemical & Biophysical Research Communications 238 (1997) 703-706
31. Gopalakrishna R., Chen Z.H., and Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. The Journal of Biological Chemistry 268 (1993) 27180-27185
32. Park H.S., Huh S.H., Kim M.S., Lee S.H., and Choi E.J. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 14382-14387
33. Teng K.K., Esposito D.K., Schwartz G.D., Lander H.M., and Hempstead B.L. Activation of c-Ha-Ras by nitric oxide modulates survival responsiveness in neuronal PC12 cells. The Journal of Biological Chemistry 274 (1999) 37315-37320
34. Xu L., Eu J.P., Meissner G., and Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279 (1998) 234-237
35. Lane P., Hao G., and Gross S.S. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification head-to-head comparison with O-phosphorylation. Science's STKE 2001 (2001) RE1
36. Gaston B.M., Carver J., Doctor A., and Palmer L.A. S-nitrosylation signaling in cell biology. Molecular Interventions 3 (2003) 253-263
37. Benhar M., and Stamler J.S. A central role for S-nitrosylation in apoptosis. Nature Cell Biology 7 (2005) 645-646
38. Wyllie A.H., Kerr J.F., and Currie A.R. Cell death: the significance of apoptosis. International Review of Cytology 68 (1980) 251-306
39. Salvesen G.S., and Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell 91 (1997) 443-446
40. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., and Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annual Reviews of Immunology 17 (1999) 331-367
41. Yuan J. Transducing signals of life and death. Current Opinions in Cell Biology 9 (1997) 247-251
42. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
43. Reed J.C. Cytochrome c: can't live with it-can't live without it. Cell 91 (1997) 559-562
44. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L.E., and Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997) 190-195
45. Klas C., Debatin K.M., Jonker R.R., and Krammer P.H. Activation interferes with the APO-1 pathway in mature human T cells. International Immunology 5 (1993) 625-630
46. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
47. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132
48. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog Bax that accelerates programmed cell death. Cell 74 (1993) 609-619
49. Ben-Ezra J.M., Kornstein M.J., Grimes M.M., and Krystal G. Small cell carcinomas of the lung express the Bcl-2 protein. American Journal of Pathology 145 (1994) 1036-1040
50. Ikegaki N., Katsumata M., Minna J., and Tsujimoto Y. Expression of bcl-2 in small cell lung carcinoma cells. Cancer Research 54 (1994) 6-8
51. Jiang S.X., Sato Y., Kuwao S., and Kameya T. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. Journal of Pathology 177 (1995) 135-138
52. Breitschopf K., Haendeler J., Malchow P., Zeiher A.M., and Dimmeler S. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Molecular Cell Biology 20 (2000) 1886-1896
53. Hochstrasser M. Ubiquitin-dependent protein degradation. Annual Reviews of Genetics 30 (1996) 405-439
54. Hershko A., and Ciechanover A. The ubiquitin system. Annual Reviews of Biochemistry 67 (1998) 425-479
55. Mannick J.B., Schonhoff C., Papeta N., Ghafourifar P., Szibor M., Fang K., and Gaston B. S-Nitrosylation of mitochondrial caspases. Journal of Cell Biology 154 (2001) 1111-1116
56. Abedini M.R., Qiu Q., Yan X., and Tsang B.K. Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro. Oncogene 23 (2004) 6997-7004
57. Lee S.H., Kim H.S., Kim S.Y., Lee Y.S., Park W.S., Kim S.H., Lee J.Y., and Yoo N.J. Increased expression of FLIP an inhibitor of Fas-mediated apoptosis in stomach cancer. APMIS 111 (2003) 309-314
58. Tanaka T., Yoshimi M., Maeyama T., Hagimoto N., Kuwano K., and Hara N. Resistance to Fas-mediated apoptosis in human lung fibroblast. The European Respiratory Journal 20 (2002) 359-368
59. Medema J.P., de Jong J., van Hall T., Melief C.J., and Offringa R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. Journal of Experimental Medicine 190 (1999) 1033-1038
60. Kinoshita H., Yoshikawa H., Shiiki K., Hamada Y., Nakajima Y., and Tasaka K. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression. International Journal of Cancer 88 (2000) 986-991
61. Buolamwini J.K. Novel anticancer drug discovery. Current Opinion in Chemical Biology 3 (1999) 500-509
62. Osford S.M., Dallman C.L., Johnson P.W., Ganesan A., and Packham G. Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Current Medicinal Chemistry 11 (2004) 1031-1039
63. Carlisle D.L., Pritchard D.E., Singh J., and Patierno S.R. Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Molecular Carcinogenesis 28 (2000) 111-118
64. Haendeler J., Hoffmann J., Tischler V., Berk B.C., Zeiher A.M., and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nature Cell Biology 4 (2002) 743-749
65. Shi X., Chiu A., Chen C.T., Halliwell B., Castranova V., and Vallyathan V. Reduction of chromium(VI) and its relationship to carcinogenesis. The Journal of Toxicological & Environmental Health Part B Critical Reviews 2 (1999) 87-104